Cargando…

Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway

Oxytocin (OT) influences various physiological functions such as uterine contractions, maternal/social behavior, and analgesia. Opioid signaling pathways are involved in one of the analgesic mechanisms of OT. We previously showed that OT acts as a positive allosteric modulator (PAM) and enhances μ-o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyano, Kanako, Yoshida, Yuki, Hirayama, Shigeto, Takahashi, Hideki, Ono, Haruka, Meguro, Yoshiyuki, Manabe, Sei, Komatsu, Akane, Nonaka, Miki, Mizuguchi, Takaaki, Fujii, Hideaki, Higami, Yoshikazu, Narita, Minoru, Uezono, Yasuhito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534029/ https://www.ncbi.nlm.nih.gov/pubmed/34685631 http://dx.doi.org/10.3390/cells10102651

Ejemplares similares

Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine
por: Mizobuchi, Yusuke, et al.
Publicado: (2022)

Evaluation of the Intracellular Signaling Activities of κ-Opioid Receptor Agonists, Nalfurafine Analogs; Focusing on the Selectivity of G-Protein- and β-Arrestin-Mediated Pathways
por: Yamaguchi, Masahiro, et al.
Publicado: (2022)

In Vitro Analyses of Spinach-Derived Opioid Peptides, Rubiscolins: Receptor Selectivity and Intracellular Activities through G Protein- and β-Arrestin-Mediated Pathways
por: Karasawa, Yusuke, et al.
Publicado: (2021)

Distinct Profiles of Desensitization of µ-Opioid Receptors Caused by Remifentanil or Fentanyl: In Vitro Assay with Cells and Three-Dimensional Structural Analyses
por: Uezono, Eiko, et al.
Publicado: (2023)

Ignavine: a novel allosteric modulator of the μ opioid receptor
por: Ohbuchi, Katsuya, et al.
Publicado: (2016)

Novel Opioid Analgesics for the Development of Transdermal Opioid Patches That Possess Morphine-Like Pharmacological Profiles Rather Than Fentanyl: Possible Opioid Switching Alternatives Among Patch Formula
por: Komatsu, Akane, et al.
Publicado: (2022)

Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol
por: Karaki, Fumika, et al.
Publicado: (2023)

Japanese Herbal Medicine Ninjinyoeito Mediates Its Orexigenic Properties Partially by Activating Orexin 1 Receptors
por: Miyano, Kanako, et al.
Publicado: (2020)

Leukemia inhibitory factor via the Toll-like receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancer-derived 85As2 cells in rats
por: Terawaki, Kiyoshi, et al.
Publicado: (2018)

Usefulness for the combination of G protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance
por: Mori, Tomohisa, et al.
Publicado: (2017)

Carboplatin Enhances the Activity of Human Transient Receptor Potential Ankyrin 1 through the Cyclic AMP-Protein Kinase A-A-Kinase Anchoring Protein (AKAP) Pathways
por: Miyano, Kanako, et al.
Publicado: (2019)

Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist
por: Doi, Seira, et al.
Publicado: (2016)

Activation mechanism of the μ-opioid receptor by an allosteric modulator
por: Kaneko, Shun, et al.
Publicado: (2022)

Mechanistic Insights into the Allosteric Modulation of Opioid Receptors by Sodium Ions
por: Shang, Yi, et al.
Publicado: (2014)

Intravenous administration of human mesenchymal stem cells derived from adipose tissue and umbilical cord improves neuropathic pain via suppression of neuronal damage and anti-inflammatory actions in rats
por: Miyano, Kanako, et al.
Publicado: (2022)

Oxytocin and Opioid Receptor Gene Polymorphisms Associated with Greeting Behavior in Dogs
por: Kubinyi, Enikő, et al.
Publicado: (2017)

Multifunctional Actions of Ninjinyoeito, a Japanese Kampo Medicine: Accumulated Scientific Evidence Based on Experiments With Cells and Animal Models, and Clinical Studies
por: Miyano, Kanako, et al.
Publicado: (2018)

Proposed Mode of Binding and Action of Positive Allosteric Modulators at Opioid Receptors
por: Shang, Yi, et al.
Publicado: (2016)

Touch-induced face conditioning is mediated by genetic variation in opioid but not oxytocin receptors
por: Fu, Yu, et al.
Publicado: (2018)

Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain
por: Bushlin, Ittai, et al.
Publicado: (2012)

Opioids in cancer: The κ-opioid receptor
por: Zhou, Qier, et al.
Publicado: (2022)

Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox
por: Zamora, Joshua C., et al.
Publicado: (2021)

Opioid Receptor-Mediated and Non-Opioid Receptor-Mediated Roles of Opioids in Tumour Growth and Metastasis
por: Scroope, Claudia A., et al.
Publicado: (2021)

Region Specific Up-Regulation of Oxytocin Receptors in the Opioid Oprm1(−/−) Mouse Model of Autism
por: Gigliucci, Valentina, et al.
Publicado: (2014)

Novel Positive Allosteric Modulators of µ Opioid Receptor—Insight from In Silico and In Vivo Studies
por: Bartuzi, Damian, et al.
Publicado: (2020)

Pharmacological profiles of opioid ligands at Kappa opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2006)

Opioid Receptors and Protonation-Coupled Binding of Opioid Drugs
por: Lešnik, Samo, et al.
Publicado: (2021)

An Emerging Role for the Delta Opioid Receptor in the Regulation of Mu Opioid Receptor Function
por: Rozenfeld, Raphael, et al.
Publicado: (2007)

Author Correction: The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis
por: Miyano, Kanako, et al.
Publicado: (2020)

The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis
por: Miyano, Kanako, et al.
Publicado: (2020)

Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities
por: Meqbil, Yazan J., et al.
Publicado: (2021)

Effects of N-Substituents on the Functional Activities of Naltrindole Derivatives for the δ Opioid Receptor: Synthesis and Evaluation of Sulfonamide Derivatives
por: Iwamatsu, Chiharu, et al.
Publicado: (2020)

Therapeutic Potential of Orally Administered Rubiscolin-6
por: Karasawa, Yusuke, et al.
Publicado: (2023)

Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors
por: Lee, Cynthia Wei-Sheng, et al.
Publicado: (2013)

Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery
por: Spetea, Mariana, et al.
Publicado: (2020)

CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2–DOP receptor heterodimer
por: Parenty, Geraldine, et al.
Publicado: (2008)

Differential Metabolic Responses to Adipose Atrophy Associated with Cancer Cachexia and Caloric Restriction in Rats and the Effect of Rikkunshito in Cancer Cachexia
por: Sudo, Yuka, et al.
Publicado: (2018)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

The organizational effects of oxytocin on the central expression of estrogen receptor α and oxytocin in adulthood
por: Kramer, Kristin M, et al.
Publicado: (2007)

Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide
por: Yang, Yin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_630a6kt857rogvhv4pjon6a892